Cited by 102Cardiovascular and exercise physiologyHeart Failure Treatment and ManagementHeart rate and cardiovascular health

Prognostic value of cardiopulmonary exercise testing in heart failure with preserved ejection fraction. The Henry Ford HospITal CardioPulmonary EXercise Testing (FIT-CPX) project

Open access
Shafiq, Ali, Brawner, Clinton A., Aldred, Heather A., Lewis, Barry, Williams, Celeste T., Tita, Christina, Schairer, John R., Ehrman, Jonathan K. +4 more·2016·American Heart Journal

Abstract

Background Although cardiopulmonary exercise (CPX) testing in patients with heart failure and reduced ejection fraction is well established, there are limited data on the value of CPX variables in patients with HF and preserved ejection fraction (HFpEF). We sought to determine the prognostic value of select CPX measures in patients with HFpEF.Methods This was a retrospective analysis of patients with HFpEF (ejection fraction ≥ 50%) who performed a CPX test between 1997 and 2010. Selected CPX variables included peak oxygen uptake (VO2), percent predicted maximum oxygen uptake (ppMVO2), minute ventilation to carbon dioxide production slope (VE/VCO2 slope) and exercise oscillatory ventilation (EOV). Separate Cox regression analyses were performed to assess the relationship between each CPX variable and a composite outcome of all-cause mortality or cardiac transplant.Results We identified 173 HFpEF patients (45% women, 58% non-white, age 54 ± 14 years) with complete CPX data. During a median follow-up of 5.2 years, there were 42 deaths and 5 cardiac transplants. The 1-, 3-, and 5-year cumulative event-free survival was 96%, 90%, and 82%, respectively. Based on the Wald statistic from the Cox regression analyses adjusted for age, sex, and β-blockade therapy, ppMVO2 was the strongest predictor of the end point (Wald χ(2) = 15.0, hazard ratio per 10%, P < .001), followed by peak VO2 (Wald χ(2) = 11.8, P = .001). VE/VCO2 slope (Wald χ(2)= 0.4, P = .54) and EOV (Wald χ(2) = 0.15, P = .70) had no significant association to the composite outcome.Conclusion These data support the prognostic utility of peak VO2 and ppMVO2 in patients with HFpEF. Additional studies are needed to define optimal cut points to identify low- and high-risk patients.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ahj.2015.12.020

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 29 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Shafiq, A., Brawner, C. A., Aldred, H. A., Lewis, B., Williams, C. T., Tita, C., Schairer, J. R., Ehrman, J. K., Velez, M., Selektor, Y., Lanfear, D. E., & Keteyian, S. J.
Affiliations
  • University of Missouri–Kansas City (US)
  • Henry Ford Hospital (US)
Corresponding author
Shafiq, Ali
Venue
American Heart Journal
Publisher
Elsevier BV
Published
2016-04
Volume
174
Pages
167-172
ISSN
0002-8703 (ISSN-L)
OpenAlex
W2234877337
Cited by
102
References
29
Citations by year
2026: 3 · 2025: 10 · 2024: 10 · 2023: 8 · 2022: 7 · 2021: 11 · 2020: 11 · 2019: 6 · 2018: 9 · 2017: 22 · 2016: 5
FWCI
28.79
Type
journal article
Language
en
Open access
Locations
  • American Heart Journal (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Heart, Lung, and Blood Institute (R01HL103871, T32HL110837)
Topics
  • Health Sciences › Medicine › Complementary and alternative medicine › Cardiovascular and exercise physiology
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart rate and cardiovascular health
Keywords
heart failure with preserved ejection fraction, cardiopulmonary exercise testing, prognostic value, peak oxygen uptake, VE/VCO2 slope, exercise oscillatory ventilation, all-cause mortality, heart transplantation, risk stratification
MeSH terms
Echocardiography, Exercise Test, Female, Follow-Up Studies, Cardiac Catheterization, Heart Failure, Humans, Male, Middle Aged, Prognosis, Retrospective Studies, Severity of Illness Index, Stroke Volume, Time Factors, United States, Reproducibility of Results, Survival Rate, Disease Progression, Disease-Free Survival, Myocardial Perfusion Imaging

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review